Voluntis

Cambridge, United States Founded: 2001 • Age: 25 yrs Listed Acquired By Aptar
Remote monitoring platform for chronic disease patients is provided.

About Voluntis

Voluntis is a Healthcare company based in Cambridge (United States) founded in 2001, and was acquired by Aptar in July 2021. Remote monitoring platform for chronic disease patients is provided. Voluntis has raised $31.19 million across 3 funding rounds from investors including Aptar, Bpifrance and Qualcomm Ventures. Voluntis offers products and services including Theraxium Platform and Digital Solutions for Life Sciences. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement. Its competitors include Welldoc, DarioHealth and Pear Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Voluntis was founded in 2001 and is based in Cambridge, United States. A remote monitoring platform is offered to healthcare providers in the digital health sector. Therapeutic education is delivered to patients with chronic diseases, while compliance is ensured and adverse events are followed up. Clinical data management and software solutions are also provided to support ongoing patient care and operations.

  • Headquarters Cambridge, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website voluntis.com
  • Social LinkedIn X Facebook
  • Acquired by Aptar (Jul 2021)
Key Metrics
  • Total Equity Funding
    $31.19M (USD)

    in 3 rounds

  • Latest Funding Round
    $7.11M (USD), Post-IPO

    Nov 2020

  • Investors
    Aptar

    & 6 more

  • Acquired by
    Aptar

    (Jul 2021)

Products & Services of Voluntis

Voluntis offers a comprehensive portfolio of products and services, including Theraxium Platform and Digital Solutions for Life Sciences.

Theraxium Platform
Digital Therapeutics Platform

Provides personalized algorithms for patient treatment enhancement

Digital Solutions for Life Sciences
Health Technology Services

Offers clinical design and regulatory support for pharma partners

Funding Insights of Voluntis

Voluntis has successfully raised a total of $31.19M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7.11 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $31.19M
  • Total Rounds 3
  • Last Round Post-IPO — $7.11M
  • First Round $2.19M

    (Jan 2007)

  • Investors Count 6

All 3 funding rounds of Voluntis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2020$7.11MPost-IPO––
–
Apr 2014$29MSeries D––
Jan 2007$2.19MSeed––
Valuation history

7 investors in total: 7 institutional.

Investors in Voluntis

Voluntis has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Aptar, Bpifrance and Qualcomm Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investing in technology sectors such as AI and automotive.
2000qualcommventures.comSan Diego, United States
Life sciences-focused VC firm investing in Europe and Canada
2007vesaliusbiocapital.comStrassen, Luxembourg
Growth and acquisition investments are managed by Credit Mutuel Equity.
creditmutuel-equity.euParis, France
Karista is recognized as an early-stage venture capital firm.
2001karista.vcParis, France
A blog on innovation and growth capital is provided.
1996innovationcapital.frParis, France
Corporate consultancy, advisory, and funding services are provided to businesses.
2012bpifrance.comMaisons Alfort, France
Regulatory support, brand differentiation, and prototyping services are provided.
1992aptar.comCrystal Lake, United States
Premium access

Investor details for Voluntis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Voluntis

5 dated milestones of Voluntis across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Voluntis is founded.
  2. Funding First funding round of $2.2M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $7.1M.
  5. Exit Acquired by Aptar.

Competitors of Voluntis

Voluntis has 3 listed competitors in our database, 3 of them funded. They include Welldoc, DarioHealth and Pear Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
welldoc.com2005Columbia, United States$72.08M65
Mobile health products for chronic disease management are offered.
dariohealth.com2011New York, United States$6.01M196
Chronic conditions are managed via a personalized digital platform.
peartherapeutics.com2013Boston, United States$266.34M207
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
Premium access

Detailed competitors of Voluntis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Voluntis

Websites that share an audience with Voluntis (voluntis.com).

Similar websites

Websites whose visitors overlap most with Voluntis. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sanofi-diabete.fr
sanofi-diabete.fr
100%
#3,033,497–
lemondedelaesante.wordpress.com
lemondedelaesante.wordpress.com
99%
–
visiosante.com
visiosante.com
89%
–

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Voluntis (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Voluntis

Premium access

Complete news archive for Voluntis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Voluntis

Voluntis was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Voluntis is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Voluntis is a funded company, having raised a total of $31.19M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.19M, raised on Jan 2007.

Voluntis was founded in 2001 and is based in Cambridge, United States. A remote monitoring platform is offered to healthcare providers in the digital health sector. Therapeutic education is delivered to patients with chronic diseases, while compliance is ensured and adverse events are followed up. Clinical data management and software solutions are also provided to support ongoing patient care and operations.

Voluntis's top competitors include Welldoc, DarioHealth and Pear Therapeutics.

Voluntis offers Theraxium Platform and Digital Solutions for Life Sciences.

Voluntis has 7 investors. Key investors include Aptar, Bpifrance, Qualcomm Ventures, Vesalius Biocapital Partners, and Innovation Capital.

Yes. Voluntis was acquired by Aptar in July 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available